Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 14.61T | 14.18T | 24.56T | 25.75T | 20.64T |
Gross Profit | 14.61T | 14.22T | 13.78T | 20.84T | 20.64T |
EBITDA | 7.31T | 7.15T | 7.37T | 6.49T | 0.00 |
Net Income | 4.45T | 4.37T | 4.67T | 4.02T | 3.41T |
Balance Sheet | |||||
Total Assets | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
Cash, Cash Equivalents and Short-Term Investments | 10.00T> | 30.40T | 29.90T | 94.37T | 92.87T |
Total Debt | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
Total Liabilities | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
Stockholders Equity | 56.05T | 53.72T | 48.44T | 47.29T | 44.07T |
Cash Flow | |||||
Free Cash Flow | -34.51T | -186.39B | 6.65T | 10.19T | -5.05T |
Operating Cash Flow | -34.25T | 529.85B | 7.59T | 11.08T | -4.41T |
Investing Cash Flow | 148.53B | -4.27T | -11.03T | -12.03T | -3.03T |
Financing Cash Flow | 38.69T | 9.76T | 3.39T | 4.96T | 7.88T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $30.34B | 8.07 | 10.66% | 2.47% | -3.00% | 32.85% | |
77 Outperform | $17.69B | 11.45 | 16.35% | 9.94% | 3.89% | 15.26% | |
74 Outperform | $14.30B | 7.25 | 9.43% | 2.37% | -0.86% | 13.17% | |
71 Outperform | $26.04B | 8.10 | 8.79% | 2.52% | -3.37% | 4.50% | |
70 Outperform | $28.37B | 9.21 | 10.61% | 0.92% | -9.78% | 27.43% | |
70 Outperform | $18.62B | 15.62 | 10.89% | 5.53% | -3.94% | 31.52% | |
68 Neutral | ¥722.98B | 10.78 | 7.55% | 3.29% | 7.93% | 15.81% |